Status:
COMPLETED
Effects of Mitopure (Urolithin A) on Skeletal Muscle Function, Iron Metabolism and Endurance Performance
Lead Sponsor:
Amazentis SA
Collaborating Sponsors:
Australian Catholic University
Conditions:
Healthy
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
This is a randomized, double-blind, placebo-controlled study enrolling 36 (16 Elite and 20 Sub-Elite trained endurance runners (18 placebo and 18 Mitopure intervention) who are 18-40 years of age. Mit...
Eligibility Criteria
Inclusion
- Age between 18-40 years
- Participants will be running \>100 km/week
- Elite participants will be required to have a 3,000 m running personal best time below 9:00 (mm:ss), and/or a VO2max result greater than 65 ml·kg-1·min-1
- The sub-elite cohort will have a 3,000 m running personal best faster than 10:00 min and/or a VO2max \>60 ml·kg-1·min-1
- Agree to participate in one of two \~4 week training camps been held between March-October 2021.
- Signed informed consent
Exclusion
- Subjects with diagnosed medical conditions involving thyroid function or other chronic disturbances of metabolic rate
- Subjects who are unable to complete the training or testing protocols
Key Trial Info
Start Date :
April 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2023
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04783207
Start Date
April 21 2021
End Date
August 30 2023
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Australian Catholic University/Australian Institute of Sports
Canberra, Australia